Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Pharmx Technologies Ltd

Healthcare AU PHX

0.105AUD
-0.005(4.55%)

Last update at 2026-03-11T04:53:00Z

Day Range

0.100.12
LowHigh

52 Week Range

0.070.20
LowHigh

Fundamentals

  • Previous Close 0.11
  • Market Cap75.84M
  • Volume65124
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.42300M
  • Revenue TTM7.65M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 1.73M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 0.08M 0.20M -0.71900M 0.30M 1.36M
Minority interest - - - - -
Net income -0.26400M -1.76900M -1.05100M 0.25M 1.09M
Selling general administrative 5.05M 2.55M 2.84M 8.22M 7.17M
Selling and marketing expenses 0.35M 0.22M 0.17M 0.26M 0.16M
Gross profit 5.96M 5.25M 4.81M 10.52M 10.77M
Reconciled depreciation 1.28M 1.20M 0.99M 2.17M 1.83M
Ebit 0.11M 0.24M -0.66500M 0.37M 1.50M
Ebitda 1.39M 1.45M 0.33M 2.54M 3.32M
Depreciation and amortization 1.28M 1.20M 0.99M 2.17M 1.83M
Non operating income net other - - - - -
Operating income -1.42300M -1.36300M -0.66500M 0.37M 1.50M
Other operating expenses 8.74M 7.85M 7.08M 13.74M 13.61M
Interest expense 0.03M 0.04M 0.05M 0.07M 0.14M
Tax provision 0.34M 0.11M 0.16M 0.28M 0.27M
Interest income 0.03M 0.04M 0.05M 0.03M 0.11M
Net interest income 0.18M 0.25M 0.06M -0.04200M -0.02800M
Extraordinary items 0.00000M -1.86400M -0.16800M 0.23M 0.01M
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.34M 0.11M 0.16M 0.28M 0.27M
Total revenue 7.32M 6.49M 6.02M 11.92M 12.70M
Total operating expenses 7.38M 6.62M 5.87M 12.34M 11.68M
Cost of revenue 1.36M 1.23M 1.21M 1.40M 1.94M
Total other income expense net 1.50M 1.56M 0.29M -0.07100M -0.13600M
Discontinued operations - - -0.16800M 0.23M 0.23M
Net income from continuing ops -0.26400M 0.10M -0.88300M 0.02M 1.09M
Net income applicable to common shares -0.26400M -1.76900M -1.05100M 0.25M 1.09M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 18.82M 29.86M 36.52M 30.77M 31.35M
Intangible assets 9.68M 10.81M 11.24M 18.61M 17.17M
Earning assets - - - - -
Other current assets 0.10M 0.08M 7.18M 1.70M 1.19M
Total liab 2.90M 13.88M 14.31M 7.57M 8.42M
Total stockholder equity 15.93M 15.97M 22.21M 23.20M 22.93M
Deferred long term liab - - - - -
Other current liab - - 10.67M 3.89M 5.57M
Common stock - - 98.41M 98.37M 98.37M
Capital stock 93.97M 93.97M 98.41M 98.37M 98.37M
Retained earnings -78.28600M -78.02200M -76.25300M -75.20200M -75.45400M
Other liab - - 2.02M 2.43M 1.99M
Good will 2.12M 2.12M 2.12M 2.12M 2.12M
Other assets - - 0.53M 0.85M 0.85M
Cash 4.17M 13.14M 12.81M 5.76M 6.48M
Cash and equivalents - - - - 6.48M
Total current liabilities 1.73M 11.95M 12.29M 5.11M 6.39M
Current deferred revenue - - 0.92M 0.08M 0.10M
Net debt - - -12.77400M -5.43300M -6.15700M
Short term debt - - 0.03M 0.30M 0.28M
Short long term debt - - - - -
Short long term debt total - - 0.03M 0.33M 0.32M
Other stockholder equity - - 0.06M 0.04M 0.02M
Property plant equipment - - 0.05M 0.60M 0.79M
Total current assets 5.76M 16.37M 22.59M 8.59M 10.42M
Long term investments - - - 0.15M 0.05M
Net tangible assets - - 8.85M 2.48M 3.65M
Short term investments - - 12.54M 5.25M -
Net receivables 0.98M 1.00M 0.95M 1.08M 0.86M
Long term debt - - - - -
Inventory - - 0.00000M 0.04M 0.03M
Accounts payable 0.52M 0.57M 0.67M 0.84M 0.43M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 0.06M 0.04M 0.02M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.31M 0.09M - - -
Deferred long term asset charges - - - - -
Non current assets total 13.07M 13.49M 13.93M 22.18M 20.93M
Capital lease obligations 0.89M 0.24M 0.03M 0.33M 0.32M
Long term debt total - - 0.00000M 0.02M 0.04M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.19900M 1.75M -3.57200M -3.63900M -6.18600M
Change to liabilities - - 7.63M -1.23700M -5.09400M
Total cashflows from investing activities - 1.75M -3.57200M -3.63900M -6.18600M
Net borrowings - - -0.31300M -0.31800M -0.43400M
Total cash from financing activities -0.13600M -4.62200M -0.32500M -0.36100M 7.18M
Change to operating activities - - -0.06700M 1.08M 0.33M
Net income -0.26400M -1.76900M -1.05100M 0.02M 1.09M
Change in cash -8.96400M 0.33M 7.05M -0.71900M 4.16M
Begin period cash flow 13.14M 12.81M 5.76M 6.48M 2.32M
End period cash flow 4.17M 13.14M 12.81M 5.76M 6.48M
Total cash from operating activities - 3.21M 10.94M 2.19M 3.16M
Issuance of capital stock - - - - 8.94M
Depreciation - - 0.75M 2.17M 1.83M
Other cashflows from investing activities - 3.33M -0.21300M 0.34M -2.09700M
Dividends paid - - - 0.00000M 0.90M
Change to inventory - - 0.03M -0.00800M 0.03M
Change to account receivables - - -0.06900M -0.22100M 3.66M
Sale purchase of stock - -4.48900M - 0.00000M -0.39200M
Other cashflows from financing activities - -0.01600M -0.32500M -0.36100M -0.46900M
Change to netincome - - 2.17M 1.22M 1.17M
Capital expenditures 1.75M 1.58M 3.36M 3.98M 4.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - 2.01M 10.13M 1.97M 2.08M
Stock based compensation - - - - -
Other non cash items - - - -2.19300M -2.91700M
Free cash flow -9.88400M 1.62M -3.35900M -1.78200M -4.08900M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PHX
Pharmx Technologies Ltd		 -0.005 4.55% 0.10 - 11.79 9.92 5.07 10.24 113.71
PME
Pro Medicus Ltd		 -2.9 2.08% 136.79 54.24 59.88 52.76 30.70 48.72 62.97
AYA
ARTRYA Ltd		 0.13 3.86% 3.50 - - 18581.28 5.50 5001.13 0.33
EIQ
Echoiq Ltd		 0.005 0.69% 0.72 - - 5118.78 26.19 4851.25 -8.2701
CGS
Cogstate Ltd		 -0.06 2.59% 2.26 24.22 19.61 6.67 5.02 4.21 13.11

Reports Covered

Stock Research & News

View All

Profile

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

Pharmx Technologies Ltd

1 Castlereagh Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Nick England Interim CEO & Exec. Chairman NA
Ms. Zoe Hillier Chief Financial Officer NA
Mr. James Nevile Chief Operating Officer NA
Ms. Eryl Baron Company Sec. NA
Mr. Tom Culver Chief Executive Officer NA
Ms. Eryl Baron Company Secretary NA
Mr. Tom Culver Chief Executive Officer NA
Ms. Eryl Baron Company Secretary NA
Mr. Tom Culver Chief Executive Officer NA
Ms. Eryl Baron Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.